Study directory

ADHD studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1740studies shown
Showing 1,021-1,032 of 1,740
Device study icon
RecruitingNCT03221244

Virtual Reality Attention Management

This summary needs review. Please check the official study record and contact the research team for details.

In Sacramento
Why is this study shown?

This study is directly about ADHD.

ADHDDeviceA study involving a tool, app, wearable, test, or medical device.From 8 Years to 12 Years
Countries
United States
Sponsor
University of California, Davis
Condition
ADHD
Other study type icon
Not Yet RecruitingNCT07125898

Decoding Central Defects in Dystrophinopathies From Diagnostic to Remediation

This summary needs review. Please check the official study record and contact the research team for details.

In Paris
Why is this study shown?

This study is directly about ADHD.

ADHDObservationalA study where researchers collect information without assigning a treatment.From 5 Years to 12 Years
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Condition
ADHD
Behavioral study icon
Not Yet RecruitingNCT07350551

Pediatric Epilepsy

This summary needs review. Please check the official study record and contact the research team for details.

In Dallas
Why is this study shown?

This study is directly about ADHD.

ADHDBehavioralFrom 3 Years to 25 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
ADHD
Drug study icon
TerminatedEUCTR 2010-019981-94

Attention Deficit Hyperactivity Disorder (ADHD) and opioid maintenance therapy. A randomized, placebo-controlled study of the efficacy of atomoxetine for treating adult ADHD in patients receiving o...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Finland
Why is this study shown?

This study is directly about ADHD.

ADHDDrug
Countries
Finland
Sponsor
HUS/ Neuropsykiatrian poliklinikka
Condition
ADHD
Drug study icon
TerminatedEUCTR 2017-000386-77

Effectiveness of Extended Release Methylphenidate in Reducing Cannabis Use in Young Cannabis-Dependent Patients with Attention Deficit Hyperactivity Disorder (ADHD)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In France
Why is this study shown?

This study is directly about ADHD.

ADHDDrug
Countries
France
Sponsor
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.